Pancreatic Cancer in the News

Pancreatic Cancer Imaging Agent Earns MabVax $1.75M SBIR Award Genetic Engineering News MabVax Therapeutics has received a contract from the National Cancer Institute under the Small Business Innovation Research Technology Program (SBIR). See all stories on this topic »
Penn Medicine Researchers Harness the Immune System to Fight ... Penn: Office of University Communications Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to ... See all stories on this topic »
Costa Rican Receives Patent for Pancreatic Cancer Vaccine The Costa Rica Star Christian Marin-Muller Costa Rica Christian Marin-Muller, molecular biologist and business manager with a PhD in molecular virology, is the 33 year old Costa ... See all stories on this topic »	The Costa Rica Star
Sandra's heartache played out in soap storyline Worcester News AFTER losing her husband to pancreatic cancer an Evesham woman was surprised to see her story playing out on television. Sandra Francis, aged 62, lost her ... See all stories on this topic »	Cotswold Journal
Firm to use cancer research from LSU's Pennington center The Advocate K94 said it is initially focusing on pancreatic cancer and is also conducting research in ovarian and breast cancer. K94 said its cancer therapies are being based ... See all stories on this topic »
Protein Receptors May Fight Mucus that Spreads, Shields Cancer ... Laboratory Equipment A “vicious cycle” produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice Univ. See all stories on this topic »	Laboratory Equipment
Researchers harness the immune system to fight pancreatic cancer Science Daily (press release) Sep. 24, 2013 — Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to ... See all stories on this topic »
MabVax Therapeutics Receives $1750000 Small Business ... MarketWatch (press release) SAN DIEGO, Sept. 24, 2013 /PRNewswire via COMTEX/ -- MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the ... See all stories on this topic »	MarketWatch (press release)
Penn Medicine Researchers Harness the Immune System to Fight ... Newswise (press release) Newswise — PHILADELPHIA -- Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of ... See all stories on this topic »
Nuvilex: the Quintessential Mid-Late Stage Biotech Opportunity MarketWatch The pancreatic cancer treatment market alone is in excess of $1B and given the potential to use the therapy to treat other cancers, Nuvilex is a pure-play cancer ... See all stories on this topic »